CD44 and neoplasm: Similarly, when analyzed separately for HPVDNA+ and HPVDNA− tumors, in the multivariate analyses adjusted for sex, stage, age, and tumor site, CD44 expression was still correlated to a favorable DFS and OS for the HPVDNA+ group, but not the HPVDNA− group (Table 3A and B).